ALMS · US market
Alumis Inc
Compare this company’s P/E and P/S using trailing results and the latest quarter. Ratios are calculated here from market capitalisation, signed ordinary or common-shareholder earnings and revenue.
Market cap US$920.65mFinancials dated 30 June 2026Price dated 1 October 2026
Core valuation
Calculation inputs
- Trailing earnings
- -US$438.96m
- Latest-quarter run-rate earnings
- -US$568.88m
- Latest fiscal-year earnings
- -US$243.33m
- Trailing revenue
- US$7.40m
- Latest-quarter run-rate revenue
- US$6.65m
- Latest fiscal-year revenue
- US$24.05m
Featured ETF and mutual-fund exposure
These public funds report this company in their latest disclosed holdings.
- XPH · State Street SPDR S&P Pharmaceuticals ETF1.70% weight · Holdings dated 21 August 2026
- PSMLX · Principal SmallCap Fund Class R60.50% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
- DLBMX · MassMutual Small Cap Opportunities Fund Class A0.44% weight · Holdings dated 30 June 2026
- IHE · iShares U.S. Pharmaceuticals ETF0.44% weight · Holdings dated 21 August 2026
- VYSYX · Voya MI Dynamic Small Cap Fund Class A0.30% weight · Holdings dated 31 May 2026
- RPMIX · Royce Small-Cap Fund Institutional Class0.26% weight · Holdings dated 30 June 2026
- TMSL · T. Rowe Price Small-Mid Cap ETF0.19% weight · Holdings dated 30 June 2026
- TQSMX · T. Rowe Price Integrated U.S. Small-Mid Cap Core Equity Fund0.19% weight · Holdings dated 30 June 2026
- FESM · Fidelity Enhanced Small Cap Core ETF0.17% weight · Holdings dated 30 June 2026
- PSOAX · JPMorgan Small Cap Value Fund Class A0.16% weight · Holdings dated 30 June 2026
Sources and limitations
Financial inputs are attributed to SEC EDGAR. Market cap is calculated locally where auditable price and share inputs are available. Missing data stays missing; losses are retained as signed values and produce a numeric signed P/E.
Open financial sourceFinancials as of 30 June 2026. Informational research, not investment advice.